Evidence map›Paper›PMID 42662529›Full record

ArticleiScience2026

Asymmetric cross-reactivity of nuclear receptors reveals an evolutionary buffer between estrogen and androgen signaling.

Shintaro Yamazaki, Akhilesh B Reddy

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Shintaro YamazakiDepartment of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Akhilesh B ReddyDepartment of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Funding

Determination of the mechanistic targets of metforminDP1DK126167 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI REDDY, AKHILESH BASI · 2020 to 2024
$3.9M
Molecular Timekeepers: Converging Pathways in Circadian ControlR35GM161590 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Akhilesh Basi Reddy · 2026 to 2026
$487k
NIDDK NIH HHS DP1 DK126167NIGMS NIH HHS R35 GM161590
6 · The paper itself

Abstract

Nuclear receptor ligand interaction landscapes remain incompletely characterized, particularly at the scale of entire receptor families. We used Boltz-2, a structure-based deep learning framework for protein-ligand affinity prediction, to perform an unbiased survey of endogenous hormones across all human nuclear receptors. This analysis revealed an asymmetric pattern within steroid hormone receptors: estradiol showed broad predicted compatibility across multiple receptors, whereas other steroid hormones did not exhibit reciprocal compatibility with estrogen receptors. To interpret this pattern, we integrated structural modeling, evolutionary analyses, physiological contextualization, and prior experimental observations, which collectively led us to propose an evolutionary buffering framework for steroid receptor interactions. This study illustrates how large-scale affinity prediction can move beyond individual receptor-ligand pairs to reveal family-level interaction architectures, generate testable hypotheses, and guide future experimental investigation.

Indexed as

artificial intelligencecomputational pharmacologyestrogen signalingevolutionligand cross-reactivitynuclear receptorprotein structure predictionsteroid receptor

Identifiers

PMID42662529
PMCPMC13521070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.